Author: BusinessWire

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative…

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.)(TOKYO:4592), a scientific leader in regenerative medicine for neurological…

Investigator-initiated trial to evaluate AVID200’s safety, anti-fibrotic activity, and ability to restore hematopoiesis in patients with myelofibrosis AVID200 is a…

DUBLIN–(BUSINESS WIRE)–The “Human Papillomavirus Associated Diseases – Pipeline Insights, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report…

DUBLIN–(BUSINESS WIRE)–The “Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…

DUBLIN–(BUSINESS WIRE)–The “Pancreatic Ductal Adenocarcinoma – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers…

IRVING, Texas–(BUSINESS WIRE)–The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of thirty-nine cents per share…

Conference Call Scheduled for Wednesday, May 8, 2019 at 4:30 p.m. ET NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…

DUBLIN–(BUSINESS WIRE)–The “Otitis Media – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…

DUBLIN–(BUSINESS WIRE)–The “Helicobacter Pylori Infections – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers…